Pantoprazole, a drug in a class PPIs, has reported to suppress the MRP1 (ABCC1) signaling pathway and reduce cell survival in drug-resistant gastric adenocarcinoma cells26. Here, ABCC1 is linked to gastric adenocarcinoma.